Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Healthy Adult Participants × repaglinide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

TP53 Y220C Mutation 1 Prostate Cancer Patients 1 Ovarian Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Healthy Adult Participants 1 Gastrointestinal Stromal Tumors 1 Advanced Solid Tumor 1 Advanced Malignancies 1

Interventions

vorasidenib 1 repaglinide 1 Rosuvastatin Calcium 1 Omeprazole 1 Midazolam 1 Flurbiprofen 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Servier

Phase 1 Completed

Healthy Adult Participants

Data powered by HemOnc (CC BY 4.0) Colophon ⚡